Production (Stage)
MediciNova, Inc.
MNOV
$1.41
$0.01991.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.98% | -36.70% | -294.44% | 8.48% | 5.59% |
| Total Depreciation and Amortization | -3.70% | -5.45% | -8.77% | 8.00% | 31.71% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 25.19% | 263.12% | 105.24% | -34.98% | -52.31% |
| Change in Net Operating Assets | 9.23% | -67.34% | 128.95% | -496.15% | -68.91% |
| Cash from Operations | 2.18% | -287.04% | -48.17% | -17.96% | -21.74% |
| Capital Expenditure | -- | -- | 100.00% | 95.16% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 107.41% | 95.16% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -160.53% | 222.47% | -568.52% | -41.62% | 230.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.87% | -278.20% | -50.28% | -17.54% | -110.50% |